Free Trial

CARGO Therapeutics (CRGX) News Today

CARGO Therapeutics logo
$17.73 -0.17 (-0.95%)
(As of 11:54 AM ET)
CARGO Therapeutics, Inc. stock logo
Sio Capital Management LLC Takes Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX)
Sio Capital Management LLC bought a new position in CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 173,860 shares of the company's stock, valued at app
FY2024 Earnings Forecast for CRGX Issued By William Blair
CARGO Therapeutics, Inc. stock logo
Equities Analysts Offer Predictions for CRGX FY2024 Earnings
CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) - William Blair issued their FY2024 earnings per share (EPS) estimates for shares of CARGO Therapeutics in a report released on Tuesday, November 26th. William Blair analyst S. Corwin anticipates that the company will post earnings of ($3.74) p
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics (NASDAQ:CRGX) Earns Outperform Rating from Analysts at William Blair
William Blair started coverage on CARGO Therapeutics in a research note on Tuesday. They issued an "outperform" rating on the stock.
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics' (CRGX) Buy Rating Reiterated at HC Wainwright
HC Wainwright restated a "buy" rating and issued a $33.00 target price on shares of CARGO Therapeutics in a research report on Friday.
CARGO Therapeutics, Inc. (CRGX) Gets a Buy from Piper Sandler
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Average Rating of "Buy" from Analysts
CARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) has been assigned a consensus rating of "Buy" from the seven analysts that are covering the firm, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1-year target price among brokera
Cargo Therapeutics announces ASH 2024 abstract on CRG-023
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Short Interest Update
CARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) was the target of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 5,430,000 shares, a growth of 7.1% from the September 30th total of 5,070,000 shares. Approximately 17.2% of the shares of the stock are sold short. Based on an average trading volume of 317,000 shares, the days-to-cover ratio is presently 17.1 days.
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics (NASDAQ:CRGX) Trading Down 5.9% - Here's Why
CARGO Therapeutics (NASDAQ:CRGX) Stock Price Down 5.9% - Here's Why
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Given Average Rating of "Buy" by Analysts
CARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) has been assigned an average recommendation of "Buy" from the seven research firms that are currently covering the firm, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average 12 month price obj
CARGO Therapeutics, Inc. stock logo
Short Interest in CARGO Therapeutics, Inc. (NASDAQ:CRGX) Rises By 21.6%
CARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 5,070,000 shares, an increase of 21.6% from the September 15th total of 4,170,000 shares. Approximately 16.1% of the shares of the stock are sold short. Based on an average trading volume of 325,200 shares, the short-interest ratio is presently 15.6 days.
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics (NASDAQ:CRGX) Trading Up 6.2% - Time to Buy?
CARGO Therapeutics (NASDAQ:CRGX) Trading 6.2% Higher - Here's What Happened
CARGO Therapeutics, Inc. stock logo
The Manufacturers Life Insurance Company Has $2.61 Million Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX)
The Manufacturers Life Insurance Company increased its position in CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) by 20.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 159,019 shares of the company's stock after
CARGO Therapeutics, Inc. stock logo
Novo Holdings A S Acquires 294,000 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX)
Novo Holdings A S grew its holdings in CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) by 23.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,544,000 shares of the company's stock after purchasi
CARGO Therapeutics, Inc. stock logo
CVI Holdings LLC Purchases New Stake in CARGO Therapeutics, Inc. (NASDAQ:CRGX)
CVI Holdings LLC acquired a new position in shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 70,000 shares of the company's stock, valued at approximately $1,14
CARGO Therapeutics, Inc. stock logo
Yu Fan Makes New Investment in CARGO Therapeutics, Inc. (NASDAQ:CRGX)
Yu Fan bought a new stake in shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 912,000 shares of the company's stock, valued at approximately $14,975,000.
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Average Rating of "Buy" from Brokerages
Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) have been assigned an average rating of "Buy" from the seven brokerages that are currently covering the company, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average 12 mon
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics, Inc. (NASDAQ:CRGX) CFO Sells $40,448.00 in Stock
CARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) CFO Anup Radhakrishnan sold 1,600 shares of the firm's stock in a transaction dated Wednesday, September 18th. The stock was sold at an average price of $25.28, for a total value of $40,448.00. Following the sale, the chief financial officer now owns 6,446 shares of the company's stock, valued at $162,954.88. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
Piper Sandler Reaffirms Their Buy Rating on CARGO Therapeutics, Inc. (CRGX)
CARGO Therapeutics, Inc. stock logo
TD Asset Management Inc Has $4.75 Million Stock Holdings in CARGO Therapeutics, Inc. (NASDAQ:CRGX)
TD Asset Management Inc boosted its stake in shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) by 78.7% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 289,352 shares of the company's stock after purchasing an additional 127,418 shares duri
CARGO Therapeutics, Inc. stock logo
Cowen AND Company LLC Buys 304,305 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX)
Cowen AND Company LLC lifted its stake in CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) by 121.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 554,305 shares of the company's stock after buying an a
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics (NASDAQ:CRGX) Trading 6.1% Higher
CARGO Therapeutics (NASDAQ:CRGX) Trading Up 6.1%
CARGO Therapeutics, Inc. stock logo
Short Interest in CARGO Therapeutics, Inc. (NASDAQ:CRGX) Drops By 6.0%
CARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) was the target of a large drop in short interest in August. As of August 15th, there was short interest totalling 4,080,000 shares, a drop of 6.0% from the July 31st total of 4,340,000 shares. Based on an average trading volume of 244,800 shares, the days-to-cover ratio is currently 16.7 days. Approximately 12.9% of the company's stock are short sold.
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics (NASDAQ:CRGX) Trading 3.9% Higher
CARGO Therapeutics (NASDAQ:CRGX) Trading 3.9% Higher
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Recommendation of "Buy" from Analysts
CARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) has been given a consensus recommendation of "Buy" by the seven ratings firms that are covering the company, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average twelve-month ta
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics (NASDAQ:CRGX) Trading Down 6.9%
CARGO Therapeutics (NASDAQ:CRGX) Stock Price Down 6.9%
CARGO Therapeutics, Inc. stock logo
Short Interest in CARGO Therapeutics, Inc. (NASDAQ:CRGX) Expands By 8.8%
CARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) was the target of a large increase in short interest during the month of July. As of July 31st, there was short interest totalling 4,340,000 shares, an increase of 8.8% from the July 15th total of 3,990,000 shares. Based on an average daily trading volume, of 203,100 shares, the days-to-cover ratio is currently 21.4 days. Currently, 13.3% of the shares of the company are short sold.
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics (NASDAQ:CRGX) Sees Unusually-High Trading Volume
CARGO Therapeutics (NASDAQ:CRGX) Sees Strong Trading Volume
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics, Inc. Expected to Post Q3 2024 Earnings of ($1.02) Per Share (NASDAQ:CRGX)
CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) - HC Wainwright cut their Q3 2024 earnings estimates for shares of CARGO Therapeutics in a report released on Tuesday, August 13th. HC Wainwright analyst R. Burns now expects that the company will earn ($1.02) per share for the quarter, down fr
CARGO Therapeutics, Inc. stock logo
CARGO Therapeutics (NASDAQ:CRGX) Stock Price Up 5.4%
CARGO Therapeutics (NASDAQ:CRGX) Trading Up 5.4%
Get CARGO Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter.

Media Is Mocking Elon, But Wait Until They See This Demo (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

CRGX Media Mentions By Week

CRGX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRGX
News Sentiment

0.73

0.87

Average
Medical
News Sentiment

CRGX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRGX Articles
This Week

12

2

CRGX Articles
Average Week

Get CARGO Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CRGX) was last updated on 12/3/2024 by MarketBeat.com Staff
From Our Partners